Shopping Cart
Remove All
Your shopping cart is currently empty
PF-06647263 (anti-EFNA4-ADC) is an ADC compound targeting EFNA4, with anti-tumor activity, composed of an anti-EFNA4 antibody conjugated with calicheamicin, inducing significant tumor regression in TNBC xenografts.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $447 | - | In Stock | |
| 5 mg | $1,400 | - | In Stock | |
| 10 mg | $2,240 | - | In Stock | |
| 25 mg | $4,210 | - | In Stock |
| Description | PF-06647263 (anti-EFNA4-ADC) is an ADC compound targeting EFNA4, with anti-tumor activity, composed of an anti-EFNA4 antibody conjugated with calicheamicin, inducing significant tumor regression in TNBC xenografts. |
| Targets&IC50 | 293T-EFNA4 cells:1 ng/mL (EC50) |
| In vitro | PF-06647263 induces antigenic and concentration-dependent cytotoxicity, and exposure to PF-06647263 for 96 hours causes 293T-EFNA4 cell death (EC50 ≈ 1 ng/mL). [1] |
| In vivo | In mice with a breast PDX tumor model, 0.27 mg/kg PF-06647263 resulted in significant tumor regression. [1] |
| Synonyms | PF06647263, anti-EFNA4-ADC |
| Molecular Weight | 145.5 kDa |
| Cas No. | 1822383-65-2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.